In accordance with Section 28a of the Danish Securities Trading Act, Novozymes reports the following transactions under ISIN DK0060336014, Novozymes B shares under the symbol NZYM B.
30. January 2014
Page Content
Name | Novo A/S |
Relation/category of close relation | Novo A/S is closely related to the chairman of Novozymes' board of directors, Henrik Gürtler |
Trading date | January 29, 2014 |
Market | Nasdaq OMX Copenhagen A/S |
Character of transaction | Sale of shares |
Volume of transaction buy(+)/ sell (-) | -59,300 |
Value of transaction (DKK) | 13,602,743.98 DKK |
This sale has been completed according to earlier communicated intention by Novo A/S to keep its relative holding of Novozymes B shares at the level it held prior to Novozymes' cancellation of B shares on 5 April 2013 (Company announcement no. 50, August, 2011).
Contact information
Investor Relations: | ||
Thomas Bomhoff (DK) | +45 3077 1226 | tsbm@novozymes.com |
Klaus Sindahl (DK) | +45 5363 0134 | ksdh@novozymes.com |
Martin Riise (USA) | +1 919 649 2565 | mrsn@novozymes.com |
Press and media: | ||
Rene Tronborg (DK) | +45 3077 2274 | retr@novozymes.com |
Frederik Bjoerndal (Europe) | +45 3077 0236 | tfbh@novozymes.com |
Paige Donnelly (USA) | +1 919 218 4501 | pagd@novozymes.com |
Meng Lian (China) | +86 136 9923 1164 | mexl@novozymes.com |
Henrique Pellini (Brazil) | +55 41 9288 0282 | hqp@novozymes.com |
Poonam Kapila (India) | +91 991 082 2339 | poka@novozymes.com |
distributed by
|